| CHDS News Stories - Recent
| |
Benefit-cost analysis is a well-established and widely used approach for systematically assessing policy impacts, as discussed by CHDS’s Lisa Robinson in a recent Free Range Podcast...
Wesley Marrero discussed his research on data-driven approaches to optimize healthcare decision making at a recent CHDS seminar. Marrero, an assistant professor in the Thayer School of Engineering at Dartmouth College...
CHDS affiliate Lisa Prosser received the Society for Medical Decision Making (SMDM) Award for Distinguished Service at the 45th North American meeting in Philadelphia in October, 2023. The award recognizes “distinguished leadership, operational, scientific educational service” to the society...
CHDS affiliates were honored with the Best Paper Award from the journal Risk Analysis at the 2023 Society for Risk Analysis annual meeting. The paper, “The Benefits and Costs of U.S. Employer COVID-19 Vaccine Mandates"...
Members of the CHDS community contributed to the 45th North American Society for Medical Decision Making (SMDM) Meeting, held in Philadelphia in October, 2023. The theme was “Innovation in Decision Making: Thinking to Tools"...
| |
CHDS seminars feature national and international decision science experts. The seminars are virtual via Zoom and require pre-registration using the link provided below.
| |
Disease Transmission Modeling for Measles Control
Tuesday, January 23, 1:00 pm ET
Measles has a long history of study as a canonical pathogen for the development of mathematical transmission models. This presentation will focus on the use of models to address questions of current interest in measles control - characterizing local disease epidemiology, highlighting data quality issues, and quantitatively informing the tradeoffs that immunization programs face. I will present example use cases demonstrating models’ applicability to broad questions salient to global policymaking bodies, and focused decisions relevant to local/national control programs in measles-endemic countries.
| |
| CHDS Publications - Selected Recent
| |
Portnoy A, Pedersen K, Sy S, Tropé A, Engesaeter B, Kim JJ, Burger EA. Cost-Effectiveness of Primary Human Papillomavirus Triage Approaches Among Vaccinated Women in Norway: A Model-Based Analysis. Int J Cancer. 2023 Dec 13. PMID: 38088449. https://doi.org/10.1002/ijc.34804
Kunst N, Burger EA, Coupé VMH, Kuntz KM, Aas E. A Guide to an Iterative Approach to Model-Based Decision Making in Health and Medicine: An Iterative Decision-Making Framework. Pharmacoeconomics. 2023 Dec 29. PMID: 38157129. https://doi.org/10.1007/s40273-023-01341-z
Chang W, Cohen J, Wang DQ, Abdulla S, Mahende MK, Gavana T, Scott V, Msuya HM, Mwanyika-Sando M, Njau RJA, Lu SN, Temu S, Masanja H, Anthony W, Aregawi W M, Sunder N, Kun T, Bruxvoort K, Kitau J, Kihwele F, Chila G, Michael M, Castro M, Menzies NA, Kim S, Ning X, Zhou XN, Chaki P, Mlacha YP. Impact of 1,7-Malaria Reactive Community-Based Testing and Response (1,7-mRCTR) Approach on Malaria Prevalence in Tanzania. Infect Dis Poverty. 2023 Dec 18;12(1):116. PMID: 38105258. https://doi.org/10.1186/s40249-023-01166-0
Verguet S, Gautam P, Ali I, Husain A, Meyer S, Burbano C, Lloyd-Evans E, Coco M, Mphangwe M, Saka A, Zelalem M, Giyose BB, Li Z, Erzse A, Hofman K, Giner C, Avallone S, Kuusipalo H, Kristjansson E, Schultz L, Bundy DAP, Angrist N. Investing in School Systems: Conceptualising Returns on Investment Across the Health, Education and Social Protection Sectors. BMJ Glob Health. 2023 Dec 18;8(12):e012545. PMID: 38114237. https://doi.org/10.1136/bmjgh-2023-012545
Kohli MA, Maschio M, Joshi K, Lee A, Fust K, Beck E, Van de Velde N, Weinstein MC. The Potential Clinical Impact and Cost-Effectiveness of the Updated COVID-19 mRNA Fall 2023 Vaccines in the United States. J Med Econ. 2023 Jan-Dec;26(1):1532-1545. PMID: 37961887. https://doi.org/10.1080/13696998.2023.2281083
Henry E, Al-Janabi H, Brouwer W, Cullinan J, Engel L, Griffin S, Hulme C, Kingkaew P, Lloyd A, Payakachat N, Pennington B, Peña-Longobardo LM, Prosser LA, Shah K, Ungar WJ, Wilkinson T, Wittenberg E. Recommendations for Emerging Good Practice and Future Research in Relation to Family and Caregiver Health Spillovers in Health Economic Evaluations: A Report of the SHEER Task Force. Pharmacoeconomics. 2023 Dec 2. PMID: 38041698. https://doi.org/10.1007/s40273-023-01321-3
Raffoul A, Ward ZJ, Santoso M, Kavanaugh JR, Austin SB. Social Media Platforms Generate Billions of Dollars in Revenue from U.S. Youth: Findings from a Simulated Revenue Model. PLoS One. 2023 Dec 27;18(12):e0295337. PMID: 38150418. https://doi.org/10.1371/journal.pone.0295337
Galbraith AA, Faugno E, Cripps LA, Przywara KM, Wright DR, Gilkey MB. "You Have to Rob Peter to Pay Paul So Your Kid Can Breathe": Using Qualitative Methods to Characterize Trade-Offs and Economic Impact of Asthma Care Costs. Med Care. 2023 Dec 1;61(12 Suppl 2):S95-S103. PMID: 37963027. https://doi.org/10.1097/MLR.0000000000001914
| |
|
Featured Resource
Collection: Cost-Effectiveness of Screening and Treatment for Hypertension
This collection provides a selection of decision analyses and cost-effectiveness analyses for screening, management and treatment of hypertension, both before and after the 2017 American College of Cardiology/American Heart Association Clinical Practice Guidelines. The resources are intended to be useful to educators seeking examples for instructional materials relevant to clinical decision making, diagnostic test performance, and cost-effectiveness analysis.
| |
|
